Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin
PTI, Jan 19, 2021, 12:54 PM IST
Image for representation
New Delhi: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its Covid-19 vaccine, Covaxin, sources said.
Out of the 45 lakh doses, the vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as goodwill gesture sources added.
“The company was given a fresh letter of comfort recently for supplying another 45 lakh doses of Covaxin. The doses will be dispatched as when the Ministry places orders with the company,” sources told PTI. After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow, it said.
Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India. Sources further said the supplies from the company depend on the orders being placed by the government.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Congress to introspect Chelakkara bypoll debacle
CRPF sets up three new forward bases in Chhattisgarh’s hardcore Naxal areas
Jasprit Bumrah, Virat Kohli my favourite cricketers: Ex-CJI D Y Chandrachud
Veg diet, alcohol abstinence, behaviour training: UP cops prep for ‘pleasant’ Maha Kumbh
Senior BJP leaders meet Fadnavis after Mahayuti’s landslide win
MUST WATCH
Latest Additions
Congress to introspect Chelakkara bypoll debacle
Kapil Dev praises Bumrah for leading team from the front
CRPF sets up three new forward bases in Chhattisgarh’s hardcore Naxal areas
Jasprit Bumrah, Virat Kohli my favourite cricketers: Ex-CJI D Y Chandrachud
Veg diet, alcohol abstinence, behaviour training: UP cops prep for ‘pleasant’ Maha Kumbh
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.